Patents by Inventor Bernhard Schilling

Bernhard Schilling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12372502
    Abstract: The present invention relates to methods for determining a slurry concentration for a slurry of a chromatography resin during a column packing. The present invention provides a more accurate and consistent method for determining a slurry concentration for packing a chromatography column. The method of the present invention utilizes an automated pump to provide a controlled flow rate to consolidate a resin sample. Based on the consolidated resin, a slurry concentration can be determined. The determined slurry concentration can be utilized to pack the resin in a chromatography column with highly accurate bed heights.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 29, 2025
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan Mao, Eric Shierly, Joseph Gallea, Raymond Feng, Tikiri Dissanayake, Bernhard Schilling, Scott Carver
  • Publication number: 20240345048
    Abstract: The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.
    Type: Application
    Filed: May 24, 2024
    Publication date: October 17, 2024
    Inventors: Nathan L. MAO, Scott CARVER, Bernhard SCHILLING, Eric SHIERLY
  • Patent number: 12025599
    Abstract: The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: July 2, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. Mao, Scott Carver, Bernhard Schilling, Eric Shierly
  • Publication number: 20230343086
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Application
    Filed: July 5, 2023
    Publication date: October 26, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. MAO, Wenbin Ql, Bernhard SCHILLING, Scott CARVER
  • Publication number: 20230273163
    Abstract: Embodiments of the present disclosure are directed to methods and systems for assessing integrity of chromatography columns, systems, and processes. The methods and systems can comprise one or more of extracting a block and signal combination for analysis, performing a transition analysis, performing one or more statistical process controls, and/or implementing in-process controls based on the statistical process controls.
    Type: Application
    Filed: May 8, 2023
    Publication date: August 31, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. MAO, Eric SHIERLY, Bernhard SCHILLING, Scott CARVER, Stefanie MCDERMOTT, John MATTILA, Hanne BAK
  • Patent number: 11717586
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: August 8, 2023
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Nathan L. Mao, Wenbin Qi, Bernhard Schilling, Scott Carver
  • Patent number: 11680930
    Abstract: Embodiments of the present disclosure are directed to methods and systems for assessing integrity of chromatography columns, systems, and processes. The methods and systems can comprise one or more of extracting a block and signal combination for analysis, performing a transition analysis, performing one or more statistical process controls, and/or implementing in-process controls based on the statistical process controls.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: June 20, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. Mao, Eric Shierly, Bernhard Schilling, Scott Carver, Stefanie McDermott, John Mattila, Hanne Bak
  • Publication number: 20230020627
    Abstract: The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.
    Type: Application
    Filed: September 27, 2022
    Publication date: January 19, 2023
    Inventors: Nathan L. MAO, Scott CARVER, Bernhard SCHILLING, Eric SHIERLY
  • Publication number: 20220404335
    Abstract: Embodiments of the present disclosure include methods and systems for detecting the presence of endotoxins in filters. For example, embodiments of the present disclosure are directed to methods and systems for improving in-process controls by detecting undesirable quantities of endotoxins in filters containing naturally-sourced materials prior to using those filters in the production of formulated drug substances.
    Type: Application
    Filed: May 26, 2022
    Publication date: December 22, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan MAO, Annamarie CRUZ, Bernhard SCHILLING, Scott CARVER
  • Patent number: 11499951
    Abstract: The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: November 15, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. Mao, Scott Carver, Bernhard Schilling, Eric Shierly
  • Publication number: 20220331468
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Application
    Filed: June 24, 2022
    Publication date: October 20, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. MAO, Wenbin QI, Bernhard SCHILLING, Scott CARVER
  • Publication number: 20220308025
    Abstract: Embodiments of the present disclosure are directed to methods and systems for assessing integrity of chromatography columns, systems, and processes. The methods and systems can comprise one or more of extracting a block and signal combination for analysis, performing a transition analysis, performing one or more statistical process controls, and/or implementing in-process controls based on the statistical process controls.
    Type: Application
    Filed: April 18, 2022
    Publication date: September 29, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. MAO, Eric SHIERLY, Bernhard SCHILLING, Scott CARVER, Stefanie MCDERMOTT, John MATTILA, Hanne BAK
  • Patent number: 11378571
    Abstract: Embodiments of the present disclosure include methods and systems for detecting the presence of endotoxins in filters. For example, embodiments of the present disclosure are directed to methods and systems for improving in-process controls by detecting undesirable quantities of endotoxins in filters containing naturally-sourced materials prior to using those filters in the production of formulated drug substances.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: July 5, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan Mao, Annamarie Cruz, Bernhard Schilling, Scott Carver
  • Patent number: 11369707
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: June 28, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Nathan L. Mao, Wenbin Qi, Bernhard Schilling, Scott Carver
  • Patent number: 11333642
    Abstract: Embodiments of the present disclosure are directed to methods and systems for assessing integrity of chromatography columns, systems, and processes. The methods and systems can comprise one or more of extracting a block and signal combination for analysis, performing a transition analysis, performing one or more statistical process controls, and/or implementing in-process controls based on the statistical process controls.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: May 17, 2022
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Nathan L. Mao, Eric Shierly, Bernhard Schilling, Scott Carver, Stefanie McDermott, John Mattila, Hanne Bak
  • Publication number: 20210388407
    Abstract: The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.
    Type: Application
    Filed: August 23, 2021
    Publication date: December 16, 2021
    Inventors: John CHEN, Shawn LAWRENCE, Amy JOHNSON, Theodore LONEY, Ravindra PANGULE, Ta-Chun HANG, Scott CARVER, Bernhard SCHILLING
  • Publication number: 20210388408
    Abstract: The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.
    Type: Application
    Filed: August 23, 2021
    Publication date: December 16, 2021
    Inventors: John CHEN, Shawn LAWRENCE, Amy JOHNSON, Theodore LONEY, Ravindra PANGULE, Ta-Chun HANG, Scott CARVER, Bernhard SCHILLING
  • Publication number: 20210138098
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Application
    Filed: January 20, 2021
    Publication date: May 13, 2021
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Nathan L. MAO, Wenbin QI, Bernhard SCHILLING, Scott CARVER
  • Patent number: 10925986
    Abstract: The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: February 23, 2021
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Nathan L. Mao, Wenbin Qi, Bernhard Schilling, Scott Carver
  • Publication number: 20200255880
    Abstract: The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.
    Type: Application
    Filed: May 1, 2020
    Publication date: August 13, 2020
    Inventors: John CHEN, Shawn M. LAWRENCE, Amy JOHNSON, Theodore LONEY, Ravindra PANGULE, Ta-Chun HANG, Scott CARVER, Bernhard SCHILLING